Scott Braunstein Insider Trading $PCRX Pacira BioSciences, Inc.
Get free email notifications about insider trading for Scott Braunstein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott Braunstein. Scott Braunstein is Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and Chief Executive Officer in MARINUS PHARMACEUTICALS INC ($MRNS) and Executive Chairman in MARINUS PHARMACEUTICALS INC ($MRNS) and Director in ArTara Therapeutics, Inc. ($PRTO) and Chief Operating Officer in Pacira Pharmaceuticals, Inc. ($PCRX) and SVP, Strategy & Corp. Dev. in Pacira Pharmaceuticals, Inc. ($PCRX) and Director in TREVENA INC ($TRVN) and in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in Esperion Therapeutics, Inc. ($ESPR).
Scott Braunstein in Pacira BioSciences, Inc.
Trading Symbol: PCRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scott Braunstein: Chief Operating Officer, SVP, Strategy & Corp. Dev.
Holdings: 20,982 shares
Current Value: $875,999
Latest Transaction: Jan 05 2018
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Scott Braunstein in Pacira BioSciences, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CNST, ESPR, MRNS, PCRX, TARA, TRVN, ZIOP
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 05 2018 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | Chief Operating Off ... | Option Exercise | A | 46.35 | 60,000 | 2,781,000 | 60,000 | |
Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 44.20 | 22,000 | 972,400 | 22,000 | |
Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 44.10 | 10,000 | 441,000 | 10,000 | |
Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Grant | A | 0.00 | 11,000 | 0 | 20,982 | 10 K to 21 K (+110.20 %) |
Jun 07 2017 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Sell | S | 43.32 | 768 | 33,271 | 9,982 | 10.8 K to 10 K (-7.14 %) |
Dec 09 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 32.35 | 20,000 | 647,000 | 20,000 | |
Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 40.34 | 17,500 | 705,950 | 17,500 | |
Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Grant | A | 0.00 | 8,750 | 0 | 10,750 | 2 K to 10.8 K (+437.50 %) |
Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 40.34 | 17,500 | 705,950 | 17,500 | |
Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Grant | A | 0.00 | 8,750 | 0 | 10,750 | 2 K to 10.8 K (+437.50 %) |
Feb 01 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Buy | P | 58.92 | 2,000 | 117,840 | 2,000 | 0 to 2 K |
Jul 15 2015 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 67.11 | 75,000 | 5,033,250 | 75,000 |
Page: 1